Aptevo Therapeutics Inc. (APVO): Operating Income
-$26.31M
Year ended 2025-12-31
-$26.89M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$26.31M | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | -$24.60M | n/m | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | -$28.88M | n/m | 2025-02-14, From 2023-01-01 |
| 2022-12-31 | -$28.64M | n/m | 2024-03-05, From 2022-01-01 |
| 2021-12-31 | -$21.40M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$27.49M | n/m | 2022-03-24, From 2020-01-01 |
| 2019-12-31 | -$40.96M | n/c | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$51.66M | n/m | 2020-03-25, From 2018-01-01 |
| 2017-12-31 | -$53.95M | n/m | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | -$138.77M | n/c | 2018-03-13, From 2016-01-01 |
| 2015-12-31 | -$61.10M | n/a | 2017-03-31, From 2015-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | 2025-12-31 | -$26.31M | n/m |
| Skye Bioscience, Inc. (SKYE) | 2025-12-31 | -$58.16M | n/m |
| BeyondSpring Inc. (BYSI) | 2025-12-31 | -$8.95M | n/m |
| Biofrontera Inc. (BFRI) | 2025-12-31 | -$11.35M | n/m |
| Elicio Therapeutics, Inc. (ELTX) | 2025-12-31 | -$37.71M | n/m |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | -$16.45M | n/m |
| CASI Pharmaceuticals, Inc. (CASIF) | 2025-12-31 | -$45.01M | n/m |
| Onconetix, Inc. (ONCO) | 2025-12-31 | -$17.86M | n/m |
| Integrated Biopharma Inc (INBP) | 2025-06-30 | $2.02M | +704.8% |
Compare APVO, SKYE, BYSI, BFRI side by side · Screen every company in Pharmaceutical Preparations ↗